JUBLPHARMA

Jubilant Pharmova Share Price

₹1,041.45
+ 89.8 (9.44%)
09 September, 2024 14:07 BSE: 530019 NSE: JUBLPHARMA ISIN: INE700A01033

Start SIP in Jubilant Pharmova

Start SIP

Jubilant Pharmova Performance

Day Range

  • Low 933
  • High 1,048
₹ 1,041

52 Week Range

  • Low 319
  • High 1,048
₹ 1,041
  • Open Price958
  • Previous Close952
  • Volume4668324

Jubilant Pharmova Chart

  • Over 1 Month + 21.25%
  • Over 3 Month + 36.19%
  • Over 6 Month + 75.03%
  • Over 1 Year + 127.16%

Jubilant Pharmova Key Statistics

P/E Ratio 30
PEG Ratio 0
Market Cap Cr
Price to Book Ratio 3
EPS 2
Dividend 0.5
Relative Strength Index 72.47
Money Flow Index 79.08
MACD Signal 36.08
Average True Range 30.91

Jubilant Pharmova Investment Rating

  • Master Rating:
  • Jubilant Pharmova has an operating revenue of Rs. 6,847.70 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 2% needs improvement, ROE of 1% is fair but needs improvement. The company has a debt to equity of 58%, which is bit higher. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 45% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 58 which is a POOR score indicating inconsistency in earnings, a RS Rating of 83 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Jubilant Pharmova Financials
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 163202170186204189
Operating Expenses Qtr Cr 166194176186213198
Operating Profit Qtr Cr 112-1142
Depreciation Qtr Cr 131312121111
Interest Qtr Cr 888766
Tax Qtr Cr -1901030
Net Profit Qtr Cr -1033-202-31
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 888948
Operating Expenses Annual Cr 768807
Operating Profit Annual in Cr 173
Depreciation Cr 4843
Interest Annual Cr 3019
Tax Annual Cr 1029
Net Profit Annual Cr 3250
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 143-65
Cash from Investing Activity Annual Cr -4031
Cash from Financing Annual Activity Cr -7823
Net Cash Flow Annual Cr 25-12
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 2,3752,415
Fixed Assets Annual Cr 748734
Total Non Current Assets Annual Cr 2,4512,430
Total Current Assets Annual Cr 541579
Total Assets Annual Cr 2,9923,008
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 149152
ROE Annual % 12
ROCE Annual % 34
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1517
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,7201,7461,6651,6671,5671,661
Operating Expenses Qtr Cr 1,4801,4871,4591,4391,4171,459
Operating Profit Qtr Cr 252271218242170219
Depreciation Qtr Cr 91101959790271
Interest Qtr Cr 717371666256
Tax Qtr Cr 18835361914
Net Profit Qtr Cr 482-5967636-98
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 6,7726,320
Operating Expenses Annual Cr 5,8025,505
Operating Profit Annual in Cr 901776
Depreciation Cr 382554
Interest Annual Cr 272188
Tax Annual Cr 9893
Net Profit Annual Cr 77-61
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 971661
Cash from Investing Activity Annual Cr -608-544
Cash from Financing Annual Activity Cr -433-157
Net Cash Flow Annual Cr -69-40
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 5,4345,399
Fixed Assets Annual Cr 4,7304,316
Total Non Current Assets Annual Cr 7,6727,394
Total Current Assets Annual Cr 3,8763,762
Total Assets Annual Cr 11,54911,157
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 343339
ROE Annual % 1-1
ROCE Annual % 63
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1413

Jubilant Pharmova Technicals

EMA & SMA

Current Price
₹1,041.45
+ 89.8 (9.44%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹898.15
  • 50 Day
  • ₹835.92
  • 100 Day
  • ₹768.55
  • 200 Day
  • ₹677.40
  • 20 Day
  • ₹901.53
  • 50 Day
  • ₹815.65
  • 100 Day
  • ₹759.61
  • 200 Day
  • ₹654.43

Jubilant Pharmova Resistance and Support

PIVOT
₹952.19
Resistance
First Resistance 969.37
Second Resistance 987.08
Third Resistance 1,004.27
RSI 72.47
MFI 79.08
MACD Single Line 36.08
MACD 34.93
Support
First Support 934.47
Second Support 917.28
Third Supoort 899.57

Jubilant Pharmova Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 734,169 25,343,514 34.52
Week 375,516 17,191,122 45.78
1 Month 428,605 15,986,977 37.3
6 Month 546,570 17,052,977 31.2

Jubilant Pharmova Result Highlights

Jubilant Pharmova Synopsis

NSE-Medical-Diversified

Jubilant Pharmova is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 784.70 Cr. and Equity Capital is Rs. 15.90 Cr. for the Year ended 31/03/2024. Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company’s Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624.
Market Cap 15,158
Sales 734
Shares in Float 7.80
No of funds 156
Yield 0.53
Book Value 6.37
U/D Vol ratio 2.9
LTDebt / Equity 10
Alpha 0.22
Beta 1.01

Jubilant Pharmova Shareholding Pattern

Owner NameJun-24Mar-24Dec-23Sep-23
Promoters 50.68%50.68%50.68%50.68%
Mutual Funds 2.25%2.27%1.5%0.42%
Insurance Companies
Foreign Portfolio Investors 19.5%19.06%20.29%23.2%
Financial Institutions/ Banks
Individual Investors 17.78%18.72%18.75%18.24%
Others 9.79%9.27%8.78%7.46%

Jubilant Pharmova Management

Name Designation
Mr. Shyam S Bhartia Chairman
Mr. Hari S Bhartia Co-Chairman
Mr. Priyavrat Bhartia Managing Director
Mr. Arjun Shanker Bhartia Joint Managing Director
Mr. Arvind Chokhany WholeTime Director & Group CFO
Dr. Ramakrishnan Arul Whole Time Director
Mr. Shirish G Belapure Independent Director
Mr. Sushil Kumar Roongta Independent Director
Mr. Vivek Mehra Independent Director
Mr. Arun Seth Independent Director
Dr. Harsh Mahajan Independent Director
Ms. Shivpriya Nanda Independent Director

Jubilant Pharmova Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Jubilant Pharmova Corporate Action

Date Purpose Remarks
2024-07-19 Quarterly Results
2024-05-29 Audited Results & Final Dividend
2024-02-02 Quarterly Results
2023-10-27 Quarterly Results
2023-07-19 Quarterly Results
Date Purpose Remarks
2024-08-02 FINAL Rs.5.00 per share(500%)Final Dividend
2023-08-10 FINAL Rs.5.00 per share(500%)Final Dividend
2022-08-12 FINAL Rs.5.00 per share(500%)Final Dividend
2021-08-06 FINAL Rs.5.00 per share(500%)Final Dividend

Jubilant Pharmova FAQs

What is Share Price of Jubilant Pharmova ?

Jubilant Pharmova share price is ₹1,041 As on 09 September, 2024 | 13:53

What is the Market Cap of Jubilant Pharmova ?

The Market Cap of Jubilant Pharmova is ₹16588.3 Cr As on 09 September, 2024 | 13:53

What is the P/E ratio of Jubilant Pharmova ?

The P/E ratio of Jubilant Pharmova is 30 As on 09 September, 2024 | 13:53

What is the PB ratio of Jubilant Pharmova ?

The PB ratio of Jubilant Pharmova is 3 As on 09 September, 2024 | 13:53

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91